Drug Approval | March 22, 2023
Zydus granted Orphan Drug Designation by USFDA for ZYIL1
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The observations are procedural in nature
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Subscribe To Our Newsletter & Stay Updated
